Ratings by Goldman Sachs (David Roman)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/27/2026 | Teladoc | TDOC | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2026 | Medline Inc | MDLN | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2026 | Livanova | LIVN | Maintain | Neutral (N/A) |
|
Details | ||
| 2/23/2026 | Tandem Diabetes Care | TNDM | Maintain | Neutral (N/A) |
|
Details | ||
| 2/23/2026 | iRhythm Technologies | IRTC | Maintain | Neutral (N/A) |
|
Details | ||
| 2/19/2026 | Insulet Corporation | PODD | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2026 | Baxter International | BAX | Maintain | Neutral (N/A) |
|
Details | ||
| 2/11/2026 | Edwards Lifesciences | EW | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2026 | Doximity Inc | DOCS | Maintain | Neutral (N/A) |
|
Details | ||
| 1/12/2026 | Medline Inc | MDLN | New Coverage | Buy (N/A) |
41.25 (43.83) |
6.25% | Details | |
| 1/9/2026 | HealthEquity, Inc | HQY | Downgrade | Sell (Neutral) |
98.51 (78.36) |
-20.45% | Details | |
| 1/9/2026 | Doximity Inc | DOCS | Upgrade | Buy (Neutral) |
43.74 (25.34) |
-42.07% | Details | |
| 1/9/2026 | Zimmer Biomet | ZBH | Downgrade | Sell (Neutral) |
94.08 (94.11) |
0.03% | Details | |
| 11/19/2025 | Medtronic, Inc. | MDT | Upgrade | Neutral (Sell) |
96.28 (90.90) |
-5.59% | Details | |
| 10/29/2025 | Beta Bionics, Inc. | BBNX | Maintain | Buy (N/A) |
|
Details | ||
| 10/22/2025 | Boston Scientific | BSX | Maintain | Buy (N/A) |
|
Details | ||
| 10/1/2025 | Cooper Companies | COO | New Coverage | Sell (N/A) |
67.67 (76.55) |
13.12% | Details | |
| 10/1/2025 | Bausch & Lomb Corp. | BLCO | New Coverage | Neutral (N/A) |
14.96 (17.06) |
14.04% | Details | |
| 10/1/2025 | Glaukos Corporation | GKOS | New Coverage | Buy (N/A) |
81.28 (107.73) |
32.54% | Details | |
| 10/1/2025 | Doximity Inc | DOCS | Downgrade | Sell (Neutral) |
75.12 (43.74) |
-41.77% | Details | |
| 10/1/2025 | Livanova | LIVN | Downgrade | Neutral (Buy) |
52.33 (63.84) |
22% | Details | |
| 10/1/2025 | Beta Bionics, Inc. | BBNX | Upgrade | Buy (Neutral) |
19.86 (10.61) |
-46.58% | Details | |
| 8/29/2025 | Carlsmed Inc | CARL | Maintain | Buy (N/A) |
|
Details | ||
| 8/25/2025 | Shoulder Innovations | SI | New Coverage | Buy (N/A) |
12.20 (13.01) |
6.64% | Details | |
| 8/19/2025 | Medtronic, Inc. | MDT | Maintain | Sell (N/A) |
|
Details | ||
| 8/17/2025 | Carlsmed Inc | CARL | New Coverage | Buy (N/A) |
0.00 (12.00) |
0% | Details | |
| 8/8/2025 | Omada Health Inc | OMDA | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Livanova | LIVN | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2025 | Baxter International | BAX | Downgrade | Neutral (Buy) |
21.76 (17.69) |
-18.7% | Details | |
| 7/17/2025 | Abbott Labs | ABT | Maintain | Buy (N/A) |
|
Details | ||
| 7/11/2025 | Medtronic, Inc. | MDT | Maintain | Sell (N/A) |
|
Details | ||
| 7/7/2025 | Baxter International | BAX | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 7/1/2025 | Omada Health Inc | OMDA | New Coverage | Buy (N/A) |
0.00 (14.05) |
0% | Details | |
| 6/4/2025 | HealthEquity, Inc | HQY | Maintain | Neutral (N/A) |
|
Details | ||
| 5/30/2025 | Beta Bionics, Inc. | BBNX | New Coverage | Neutral (N/A) |
14.43 (10.61) |
-26.47% | Details | |
| 5/30/2025 | DexCom | DXCM | New Coverage | Buy (N/A) |
86.98 (68.10) |
-21.71% | Details | |
| 5/30/2025 | Insulet Corporation | PODD | New Coverage | Buy (N/A) |
323.55 (237.01) |
-26.75% | Details | |
| 5/21/2025 | Doximity Inc | DOCS | Maintain | Neutral (N/A) |
|
Details | ||
| 5/2/2025 | Becton Dickinson | BDX | Downgrade | Neutral (Buy) |
207.09 (167.12) |
-19.3% | Details | |
| 3/31/2025 | Kestra Medical Technologies | KMTS | New Coverage | Neutral (N/A) |
23.43 (23.04) |
-1.66% | Details | |
| 3/11/2025 | GE HealthCare | GEHC | Upgrade | Buy (Neutral) |
86.58 (74.27) |
-14.22% | Details | |
| 3/10/2025 | Livanova | LIVN | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2025 | Abbott Labs | ABT | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2025 | Teladoc | TDOC | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2025 | Tandem Diabetes Care | TNDM | Maintain | Neutral (N/A) |
|
Details | ||
| 3/3/2025 | Solventum | SOLV | Maintain | Sell (N/A) |
|
Details | ||
| 3/3/2025 | Livanova | LIVN | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2025 | Baxter International | BAX | New Coverage | Buy (N/A) |
35.08 (21.76) |
-37.97% | Details | |
| 2/24/2025 | iRhythm Technologies | IRTC | Maintain | Neutral (N/A) |
|
Details | ||
| 2/18/2025 | Teladoc | TDOC | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2025 | Doximity Inc | DOCS | Maintain | Neutral (N/A) |
|
Details | ||
| 1/30/2025 | Stryker | SYK | Maintain | Neutral (N/A) |
|
Details | ||
| 12/16/2024 | iRhythm Technologies | IRTC | Maintain | Neutral (N/A) |
|
Details | ||
| 12/5/2024 | Edwards Lifesciences | EW | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2024 | HealthEquity, Inc | HQY | New Coverage | Neutral (N/A) |
94.80 (98.51) |
3.91% | Details | |
| 11/15/2024 | Teladoc | TDOC | New Coverage | Buy (N/A) |
9.57 (5.08) |
-46.92% | Details | |
| 11/15/2024 | Doximity Inc | DOCS | New Coverage | Neutral (N/A) |
52.86 (25.34) |
-52.06% | Details | |
| 11/8/2024 | Solventum | SOLV | Maintain | Sell (N/A) |
|
Details | ||
| 10/30/2024 | Edwards Lifesciences | EW | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2024 | Tandem Diabetes Care | TNDM | New Coverage | Neutral (N/A) |
41.17 (21.14) |
-48.65% | Details | |
| 10/4/2024 | iRhythm Technologies | IRTC | New Coverage | Neutral (N/A) |
71.03 (123.59) |
74% | Details | |
| 10/4/2024 | Livanova | LIVN | New Coverage | Buy (N/A) |
53.76 (63.84) |
18.75% | Details | |
| 8/21/2024 | Medtronic, Inc. | MDT | Maintain | Sell (N/A) |
|
Details | ||
| 8/12/2024 | Solventum | SOLV | Maintain | Sell (N/A) |
|
Details | ||
| 8/7/2024 | Baxter International | BAX | Maintain | Neutral (N/A) |
|
Details | ||
| 7/26/2024 | Edwards Lifesciences | EW | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 7/10/2024 | Solventum | SOLV | Maintain | Sell (N/A) |
|
Details | ||
| 6/12/2024 | Baxter International | BAX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/30/2024 | GE HealthCare | GEHC | New Coverage | Neutral (N/A) |
78.75 (86.58) |
9.94% | Details | |
| 5/30/2024 | Medtronic, Inc. | MDT | New Coverage | Sell (N/A) |
82.00 (96.28) |
17.41% | Details | |
| 5/30/2024 | Zimmer Biomet | ZBH | New Coverage | Neutral (N/A) |
116.33 (94.08) |
-19.13% | Details | |
| 5/30/2024 | Solventum | SOLV | New Coverage | Sell (N/A) |
59.86 (69.41) |
15.95% | Details | |
| 5/30/2024 | Baxter International | BAX | New Coverage | Neutral (N/A) |
33.85 (35.08) |
3.63% | Details | |
| 5/30/2024 | Abbott Labs | ABT | New Coverage | Buy (N/A) |
101.95 (109.56) |
7.46% | Details | |
| 5/30/2024 | Becton Dickinson | BDX | New Coverage | Buy (N/A) |
226.80 (207.09) |
-8.69% | Details | |
| 5/30/2024 | Intuitive Surgical | ISRG | New Coverage | Buy (N/A) |
401.03 (490.16) |
22.23% | Details | |
| 5/30/2024 | Stryker | SYK | New Coverage | Neutral (N/A) |
339.31 (364.56) |
7.44% | Details | |
| 5/30/2024 | Edwards Lifesciences | EW | New Coverage | Buy (N/A) |
87.04 (81.64) |
-6.2% | Details | |
| 5/30/2024 | Boston Scientific | BSX | New Coverage | Buy (N/A) |
75.17 (71.35) |
-5.08% | Details |
